Hodgkin's lymphoma (relapsed or refractory): autologous stem cell therapy.

In this systematic overview, we categorised the efficacy for one intervention, based on information relating to the effectiveness and safety of high-dose chemotherapy plus autologous stem cell therapy (versus conventional chemotherapy).